BeOne Medicines
ONC
#652
Rank
$35.73 B
Marketcap
$322.90
Share price
-2.56%
Change (1 day)
55.52%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): $0.65

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is $0.65. In 2024 the company made an earnings per share (EPS) of -$6.24.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$0.65-110.42%
2024-$6.24
2022-$19.5028.21%
2021-$15.21-19.96%
2020-$19.0020.81%
2019-$15.7331.52%
2018-$11.96417.57%
2017-$2.31-37.16%
2016-$3.68158.95%
2015-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-$0.95-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-$0.24-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA